Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

TNT will assess further benefits of Lipitor

April 7, 1998

Elevated plasma P-selectin levels are associated with hypercholesterolemia

April 7, 1998

Baxter suspends study of HemAssist in U.S. trauma patients; other trials continue

April 6, 1998

Highly potent GH secretatogues discovered by Merck & Co.

April 6, 1998

Agents for hyperlipidemia under investigation at HMR

April 6, 1998

FDA approves Actonel for Paget's disease

April 3, 1998

Redux adverse effects reviewed at ACC

April 3, 1998

Gliatech's H3 antagonists show potential for treating obesity

April 3, 1998

NTE-122: effects on lipid metabolism and secretion in vitro

April 2, 1998

Merck & Co. identifies orally active, short-acting GH secretatogue

April 2, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...